TipRanks
Go Ultimate75% OFF

Auxly Cannabis Group (CBWTF) Stock Price & Analysis

664 Followers

CBWTF Stock Chart & Stats

$2.57$0.09(3.51%)
At close: 4:00 PM EST
$2$2.25$2.5Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$2.46 - $2.57
52-Week Range
$1.06 - $2.75
Previous Close
$2.48
Volume
N/A
Average Volume (3M)
28.39K
Market Cap
$264.08M
Enterprise Value
$301.99M
Total Cash (Recent Filing)
$38.95M
Total Debt (Recent Filing)
$53.67M
Price to Earnings (P/E)
10.8
Beta
0.52
Next Earnings
Nov 12, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And EBITDA Growth

Double-digit revenue growth alongside faster adjusted EBITDA expansion indicates stronger operating scale and sustained product demand. Maintaining a 31% EBITDA margin for five consecutive quarters provides evidence that growth is translating into durable profitability rather than relying only on volume increases.

Structural Margin Improvement

The margin improvement is supported by several operational levers, including cultivation yields, manufacturing efficiency, procurement savings and mix. Because these initiatives can persist across production cycles, they offer a foundation for protecting profitability as the business continues to scale.

Strong Cash Generation And Moderate Leverage

Positive operating and free cash flow, combined with materially lower leverage, gives Auxly greater capacity to fund operations and planned investment internally. This strengthens financial flexibility and reduces dependence on external financing while management executes its growth and capacity plans.

Bears Say

Margin Compression Risk

The decline in gross margin and slower TTM revenue growth show that recent profitability gains have not been fully consistent across periods. If cost or pricing pressure persists, it could reduce operating leverage and make future earnings more sensitive to product mix and execution.

Multi-year Expansion Execution Risk

The planned capacity program could improve future output, but its benefits depend on completing grow-zone, HVAC and post-harvest upgrades over several years. Delays, weaker cash generation or implementation problems could defer yield gains and reduce funding flexibility during expansion.

Higher SG&A Pressure

Higher selling, general and administrative spending can dilute the benefit of stronger gross profit if costs grow faster than revenue. Although management intends to align SG&A growth with sales, continued investment creates an ongoing risk to margin conversion during the expansion phase.

Auxly Cannabis Group News

CBWTF FAQ

What was Auxly Cannabis Group’s price range in the past 12 months?
Auxly Cannabis Group lowest stock price was $1.06 and its highest was $2.75 in the past 12 months.
What is Auxly Cannabis Group’s market cap?
Auxly Cannabis Group’s market cap is $264.08M.
When is Auxly Cannabis Group’s upcoming earnings report date?
Auxly Cannabis Group’s next earnings report is estimated for Nov 12, 2026 (not yet confirmed), which is in 4 days.
How were Auxly Cannabis Group’s earnings last quarter?
Auxly Cannabis Group released its earnings results on Aug 13, 2026. The company reported $0.05 earnings per share for the quarter.
Is Auxly Cannabis Group overvalued?
According to Wall Street analysts Auxly Cannabis Group’s price is currently Undervalued.
Does Auxly Cannabis Group pay dividends?
Auxly Cannabis Group does not currently pay dividends.
What is Auxly Cannabis Group’s EPS estimate?
Auxly Cannabis Group’s EPS estimate is 0.06.
How many shares outstanding does Auxly Cannabis Group have?
Auxly Cannabis Group has 103,235,435 shares outstanding.
What happened to Auxly Cannabis Group’s price movement after its last earnings report?
Auxly Cannabis Group reported an EPS of $0.05 in its last earnings report. Following the earnings report the stock price went down -6.913%.
Which hedge fund is a major shareholder of Auxly Cannabis Group?
Currently, no hedge funds are holding shares in CBWTF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology